logo
Sign in

ENDV Stock Price, Chart, Stats & News

Endonovo Therapeutics, Inc.
Save

Endonovo Therapeutics, Inc. (ENDV) does not currently pay a dividend.

31,875
Market cap
Current P/E
Forward P/E

ENDV chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Endonovo Therapeutics, Inc., a biotechnology company, specializes in the development, manufacturing, and distribution of non-invasive electroceutical medical devices designed for regenerative medicine applications. The company's primary offering is SofPulse, an advanced non-invasive therapeutic device that employs electroceutical technology. SofPulse is engineered to provide palliative relief for various conditions, including soft tissue injuries, chronic wounds, and post-operative pain and edema.

Similar securities

Based on sector and market capitalization

Report issue